What's hot

Bella Mehta bella_mehta

1 year 3 months ago

Planetary health session #EULAR2024 Need to consider these in managing patients. We in healthcare are contributing to emissions significantly! @RheumNow https://t.co/Gxyrm5drCE

David Liew drdavidliew

1 year 3 months ago

PMR patients get too much steroid. Data across 27 million people in England, n=39,438 with PMR. The blue are getting more pred than guidelines. Like everything in rheum: we need to be giving less pred, not more. Lumping PMR in with GCA won’t help. #EULAR2024 POS0411 @RheumNow https://t.co/bsi3lrAafm

https://twitter.com/drdavidliew/status/1801956714486317281/photo/1

Bella Mehta bella_mehta

1 year 3 months ago

#EULAR2024 POS0467 - Periodontal disease related tot he development of #RA ACPA positive and negative pts. Tooth extraction in CCP positive pts was associated. Need tooth history in RA. @RheumNow https://t.co/b9Nb3cd0kd

Md Yuzaiful Md Yusof Yuz6Yusof

1 year 3 months ago

Signing off from #EULAR2024 Vienna 🇦🇹. Well done team on your hard work and comprehensive coverage 👊🏾🙌🏻 @drdavidliew @synovialjoints @AurelieRheumo @bella_mehta @DrMiniDey @Janetbirdope @drpnash @RheumKay @JointMD @andreafava @RheumNow Safe travel 🧳 ✈️🫶🏼 https://t.co/PGtaM02A6j

https://twitter.com/Yuz6Yusof/status/1801956558185615538/photo/1

Bella Mehta bella_mehta

1 year 3 months ago

Could dogs smell RA? lol...! Exhaled breath experimental study to diagnose RA? Volatile organic compounds can detect RA? #EULAR2024 @RheumNow https://t.co/FiHsZ522In

Dr. Antoni Chan synovialjoints

1 year 3 months ago

Work ability is impaired in the majority of axSpA patients as measured by the WAI score. 996 patients were included with a mean WAI score of 31.7. Overall, 28%/43% of patients were in poor/moderate work ability, were older, more often obese , had lower education level and… https://t.co/D7oFn31Of5 https://t.co/g79riND9AO

Bella Mehta bella_mehta

1 year 3 months ago

Deep B cell depletion strategies for Drug resistant RA @RheumNow #EULAR2024 for those which dont want to use CAR-T cells / other options. Maybe used in other diseases. https://t.co/joRhfWaiDs

Mrinalini Dey DrMiniDey

1 year 3 months ago

Is Izokibep the new kid on the block in PsA? ➡️ IL-17A inhibitor ➡️ Complete resolution of enthesitis at 16w ➡️ Overall good safety data LBA0005 #EULAR2024 @RheumNow https://t.co/8htPOz9YCG

Md Yuzaiful Md Yusof Yuz6Yusof

1 year 3 months ago

#EULAR2024 POS0326 Multicentre cohort in Italy (N=67) showed Benralizumab and Mepolizumab 300mg (EGPA dose) exhibited a significant steroid-sparing effect, with MEPO300 demonstrating superior drug survival. MEPO100 (eosinophilic asthma dose) was numerically inferior @RheumNow

Peter Nash drpnash

1 year 3 months ago

EULAR OP0041 (2024) COMPARISON OF b/tsDMARDs ABOUT NON-INFLAMMATORY PAIN IN PATIENTS WITH RHEUMATOID ARTHRITIS–ANSWER LONGITUDINAL COHORT STUDY. 25% RA have significant non-inflammatory pain https://t.co/XWnzuVMlbn @RheumNow #EULAR2024

EULAR Abstract Archive

Dr. Antoni Chan synovialjoints

1 year 3 months ago

Reassessment of the cut-off values for ASDAS disease activity states in a large, multinational cohort of axSpA patients resulted in cut-offs largely similar to the currently endorsed cut-offs of 1.3, 2.1 and 3.5. Cut-off values between ID and LDA and between LDA and HDA, however,… https://t.co/vECCsmTggW https://t.co/XU7BQBYBdQ

Peter Nash drpnash

1 year 3 months ago

EULAR OP0092 (2024) INFECTIONS IN PATIENTS WITH RA TREATED WITH JAKi COMPARED TO bDMARDs: AN INTERNATIONAL COLLABORATION OF REGISTERS (THE “JAK-POT” STUDY) TNF,OMA,JAK 7-10/100 pt.yr no signif diff except for zoster >30,000pts https://t.co/XWnzuVMlbn @RheumNow #EULAR2024

EULAR Abstract Archive

Mrinalini Dey DrMiniDey

1 year 3 months ago

#EULAR2024 highlight from Prof Pitzalis & team- synovial phosphoproteome analysis in late-stage RA identifies signalling pathways assoc with pathotype & response to RTX & TOC Study highlights active signalling pathways assoc with pathotype & drug response OP0218 @RheumNow https://t.co/RZMSgj9T6k